Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 137 publications
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).
Journal: American journal of hematology
Published: June 25, 2026
All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia.
Journal: The New England journal of medicine
Published: June 03, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.
Journal: Blood cancer journal
Published: March 13, 2026
Ravulizumab-danicopan combination therapy in PNH management.
Journal: Clinical advances in hematology & oncology : H&O
Published: December 30, 2025
Genomics of Acute Myeloid Leukemia at Diagnosis and Remission.
Journal: medRxiv : the preprint server for health sciences
Published: December 17, 2025
Analysis of epidemiologic factors and treatment effects on immunophenotypes in hematologic malignancy patients.
Journal: Leukemia & lymphoma
Published: November 13, 2025
Generation of an induced pluripotent stem cell line CGOi001-A from a patient with hereditary thrombocytopenia and a germline ANKRD26 mutation.
Journal: Stem cell research
Published: October 27, 2025
Generation of an induced pluripotent stem cell line CGOi001-A from a patient with hereditary thrombocytopenia and a germline ANKRD26 mutation.
Journal: Stem cell research
Published: October 27, 2025
Decitabine-cedazuridine in patients with MDS and TP53 mutations.
Journal: Blood advances
Published: July 11, 2025
Last Updated: 09/26/2026